L-Methionine, N-[(2S)-2-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]- manufacturers
- SCH-42354
-
- $2140.00
-
2026-07-27
- CAS:144505-58-8
- Purity:
- Supply Ability: 10g
|
| | L-Methionine, N-[(2S)-2-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]- Basic information |
| | L-Methionine, N-[(2S)-2-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]- Chemical Properties |
| Boiling point | 603.0±55.0 °C(Predicted) | | density | 1.204±0.06 g/cm3(Predicted) | | pka | 3.35±0.10(Predicted) |
| | L-Methionine, N-[(2S)-2-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]- Usage And Synthesis |
| Uses | SCH-42354 is a potent, orally active neutral endopeptidase (NEP) inhibitor, is the pharmacologically active form of the proagent SCH-42495. SCH-42354 inhibits the hydrolysis of NEP to enhance the activity of atrial natriuretic peptide (ANP). SCH-42354 inhibits hydrolysis of leu-enkephalin and ANF with IC50 values of 8.3 nM and 10.0 nM, respectively. SCH-42354 has antihypertensive activity[1][2]. | | References | [1] Thompson JS, et, al. Neutral endopeptidase inhibition increases the potency of ANP in isolated rat pulmonary resistance vessels and isolated blood perfused lungs. Pulm Pharmacol. 1995 Apr-Jun;8(2-3):143-7. DOI:10.1006/pulp.1995.1018
[2] Watkins RW, et, al. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor. Am J Hypertens. 1993 May;6(5 Pt 1):357-68. DOI:10.1093/ajh/6.5.357 |
| | L-Methionine, N-[(2S)-2-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]- Preparation Products And Raw materials |
|